Skip to main content
← All exclusions

Precigen Inc

PGEN

Health Care

2

exclusion reasons

1 theme

Animal Welfare (2)
PGEN Health Care Current as of March 2026

Precigen Inc is screened out under 2 exclusion reasons spanning 1 issue category.

This page is part of our public exclusion list — a transparency tool that shows which companies we screen out and why. It is not investment advice, and it is not an accusation. It is a statement of values.

Animal Exploitation
Since Jan 3, 2022

Precigen Inc is a biotechnology company whose business model is built on animal testing. Its lead product, PAPZIMEOS, received FDA approval in August 2025 following clinical trials that required animal testing for safety and efficacy validation. The company’s public statements acknowledge that animal research is integral to its operations, stating “animal welfare is always a priority” in the context of its research and development activities. As a commercial-stage biotech firm, its pipeline and product commercialization are fundamentally dependent on the continued use of animals in laboratory research.

Animal Testing & Research
Since Jan 3, 2022

Relies on commercial in vivo preclinical testing with animal models (Hartley guinea pigs) for gene and cellular therapeutic development

Research Sources 1 organization
Cruelty Free Investors
External

Wondering what we do invest in?

The Naughty List

A digest of changes to our exclusion list — new additions, removals, and the evidence behind them. We review the list continuously as new evidence surfaces.

RSS feed No spam · Unsubscribe anytime

Companies appear on our exclusion list based on our investment judgment — not because they've done anything illegal. This is a difference of values and opinion, not an accusation of wrongdoing. Exclusion does not constitute a recommendation against investing in any company, and absence from the list does not constitute a recommendation to invest.

This information is provided for educational and transparency purposes only and should not be relied upon as investment advice. Data is drawn from independent watchdogs, NGOs, government registries, and Ethical Capital's ongoing research — see Research Sources for the full list.

Ethical Capital LLC is a state-registered investment adviser in Utah (CRD #316032). Registration does not imply a certain level of skill or training.